Viral Hepatitis Flashcards

1
Q

What Hepatitis is DNA and what are all the others

A

HBV is DNA

The rest are SSRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acute Hepatitis Stages

A

1) Several week incubation
2) Prodrome (malaise, fatigue, hepatomegaly/tenderness, dark urin gray stools, LFT are high
3) Clinical Illness (jaundance, massive immune response, hepatic encephalopathy if build up of ammonia)
4) Resolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Complications of Acute Hepatitis

A

Sepsis
Lactic Acidosis
DIC
Fulminant hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chronic Hepatitis

A

Only with HBV/HDV and HCV
Continual viral replications BEYOND 6 MONTHS
Symptoms: hepatocyte death, fibrosis and nodule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Complications of Chronic Hepatitis

A

Portal hypertension (block in the vein into the liver)
Ascites
Cirrhosis and hepatocellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diagnosis of Hepatitis

A

LFT (increased ALT and AST)
Virus serology
PCR for viral genome (false positives)
IgM/IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hepatitis A Transmission

A

Fecal-Oral Transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hep A Incubation

A

Incubation period of 25 days which malaise and jaundice lasting 2-3 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hep A progression

A

Life-long immunity

1% develop fulminant hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hep A Prevention

A

Vaccine (Havrix and Vaqta-inactivated virus) and gamma globulin immunoglobulin
NO TREATMENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hep E

A

Fecal-oral transmission
NO vaccine
Pregnant + 3rd trimester + HEV = risk of fulminant hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Common Characteristics of Hep B, C, and D

A

Infection by blood content
Chronic hepatitis development
Carriers are possible!!!
Predisposes to liver cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hep B General

A

DNA
Worldwide problem
Leading cause of chronic, cirrhosis and cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hep B Incubation

A

1-6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hep B Diagnosis

A
Surface antigen (ABsAg)
Core antigens (HBcAg)
Infectious antigen (HBeAg)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HBV Replication

A

Viron attach to hepatocyte cell surface receptor
DNA converted into circular DNA
Viral DNA is transcribed to host RNA and codes for viral proteins via host ribosomes
Viral DNA is synthesized by reverse transcription
Goes to cytoplasm and either bud out or keep replicating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

HBV Caveat

A

The virus is not pathogenic to cells but the immune response is cytotoxic to hepatocytes

18
Q

Drug target in HBV replication

A

Viral reverse transcription and DNA polymerase

19
Q

HBV Acute Infection

A
Last 4-6 weeks
90% are self-healing
1-3% develop into fulminant
Symptoms: malaise, waekness, myalgias and arthralgis
NOT CYTOPATHIC, injury is immune related
20
Q

HBV Chronic Infection

A

10-15% are carriers
HBsAg present for greater than 6 months
20% have cirrhosis
MOST ONCOGENIC VIRUS KNOWN

21
Q

Acute HBV Time Course

A

Antigens go up and then come back down within 4-8 weeks

22
Q

Chronic HBV Time Course

A

Expression goes up and takes forever to come down

23
Q

HBV Treatment/Prevention

A
Vaccine (95% successful)
Avoid glucocorticoids (prednisone = immunosuppression)
T: interferone + ribavirn or lamivudine or liver transplant
24
Q

HDV General

A

Incomplete RNA virus

Needs HBV coat protein which = more severe than HBV alone

25
Q

HCV type, most common subtype, duration, risk

A

RNA virus - cytotoxic which cause immune induced hepatic damage
Single protein that is cleaved into multiples via protease NS3
(1a is most common)
Last 12 months (acute)
High risk of becoming chronic and causing cancer
COMMONLY CO-INFECTED WITH HIV!!!!

26
Q

HCV Diagnosis, symptoms, complications

A

Asymptomatic found through high transaminases
Liver biopsy shows ongoing liver damage
Extrahepatic complications excists

27
Q

HCV Prevention and Treatment

A

No vaccine

T: Interferon + Ribavirin

28
Q

Chornic HCV Time Course

A

Levels go up and come back down and then go up and level out

29
Q

Interferon Alpha Use and MOA

A

HBV and HCV
Induce protection against viral attach in neighboring cells (inhibits protein synthesis)
HCV Specific: via induced JACK/STAT pathway and causes lots of (antiviral) proteins to prevent replication of HCV and stimulates other cytokines/immune response

30
Q

Interferon + HCV

A

Induces sustained HCV clearance (lower response in subtype 1 and 4)
Use pegylated IFN (increased response rate)
COMBINATION with ribavirin improves therapeutic response

31
Q

IFN alpha 2A and 2b drugs

A

Roferon (2a)

IntronA (2b)

32
Q

Other IFN drugs

A

IFN alfacon-1

Pegays and Peg-Intron are IFN + PEG

33
Q

***Specific to PegIFN

A

Once weekly
Increased response rate
SQ

34
Q

Cons of IFN

A

expensive!!!

Half-life is short but effects are long

35
Q

AE of IFN

A

Flu-like symptoms
CI: Cardiac Disease and pregnancy, depression
Myelosuppresion

36
Q

Ribavirin brand and MOA

A

Copegus for HCV - PO
GUANOSINE analog
Inhibits purine metabolism and viral RNA polymerase and induces mutations in viral genome

37
Q

Ribavirn CI

A

***Teratogenic!!!!
Accumulates with erythrocytes, anemia and osmotic hemolysis
Thalassemia
Sickle-cell disease or renal failure

38
Q

Lamivudine MOA and Use

A

Epivir for HBV
CYTOSINE analog
Inhibits DNA polymerase
FIRST LINE DRUG for HBV

39
Q

Lamivudine SE/problems

A

Bacterial infections

Virus can become resistant via mutations

40
Q

Alternatives to Lamivudine

A

Adefovir or entecavir (baraclude)

41
Q

Prevention of Hep Infections

A
Avoid contact with blood
Avoid sexual contact with infected person (safe sex)
Avoid IV drugs
Wash hands
Vaccines (HAV/HBV)